Sender Jankiel Miszputen

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Heda M B S Amarante et al. · World Journal of Gastroenterology · 2019 · 87 citations · Full text

Medicine, Health Sciences, Gastroenterology +13

Nutritional follow-up of patients with ulcerative colitis during periods of intestinal inflammatory activity and remission

Juliana Ripoli, Sender Jankiel Miszputen, Orlando Ambrogini et al. · Arquivos de Gastroenterologia · 2010 · 52 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

The anti-inflammatory potential of phenolic compounds in grape juice concentrate (G8000™) on 2,4,6-trinitrobenzene sulphonic acid-induced colitis

Ana Paula Ribeiro PAIOTTI, Ricardo Artigiani Neto, Patrícia Gelli Feres de Marchi et al. · British Journal Of Nutrition · 2013 · 35 citations · Full text

Agriculture, Nutritional Sciences, Pharmacology +17

Immunoexpression of cyclooxygenase-1 and -2 in ulcerative colitis

Ana Paula Ribeiro PAIOTTI, Ricardo Artigiani Neto, N.M. Forones et al. · Brazilian Journal of Medical and Biological Research · 2007 · 29 citations · Full text

Veterinary Medicine, Immunology, Pathology +17